Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Autolus Therapeutics Plc ADR (NQ: AUTL )

2.640 +0.130 (+5.18%)
Streaming Delayed Price Updated: 4:00 PM EST, Nov 30, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 73,650
Open 2.520
Bid (Size) 2.500 (1)
Ask (Size) 2.860 (18)
Prev. Close 2.510
Today's Range 2.520 - 2.670
52wk Range 1.960 - 6.940
Shares Outstanding 52,346,231
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Autolus Therapeutics announces handover of first clean rooms of new Stevenage, UK, manufacturing facility
From Autolus Therapeutics plc
Via Globe NewsWire
12 Health Care Stocks Moving In Tuesday's After-Market Session
 
Via Benzinga

Performance

YTD
-51.65%
-51.65%
1 Month
-7.37%
-7.37%
3 Month
-20.00%
-20.00%
6 Month
+3.53%
+3.53%
1 Year
-58.94%
-58.94%

More News

Read More
Autolus Therapeutics to Present Three Clinical Data Updates at the American Society of Hematology (ASH) Annual Meeting 2022
From Autolus Therapeutics plc
Via Globe NewsWire
Autolus Therapeutics: Q3 Earnings Insights
Via Benzinga
Moderna In-Licenses Autolus' Technology For mRNA-Based Cancer Therapeutics
Via Benzinga
Recap: Autolus Therapeutics Q2 Earnings
Via Benzinga
Earnings Scheduled For March 10, 2022
Via Benzinga
Autolus Therapeutics Reports Third Quarter 2022 Financial Results and Operational Progress
From Autolus Therapeutics plc
Via Globe NewsWire
Autolus Therapeutics to Report Third Quarter 2022 Financial Results on November 3, 2022
From Autolus Therapeutics plc
Via Globe NewsWire
Moderna exercises option to license proprietary targeting technology from Autolus
From Autolus Therapeutics plc
Via Globe NewsWire
11 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
R&D Efforts to Improve Optimal Treatments for Advanced Pancreatic Ductal Adenocarcinoma (PDAC) Progressing
Via FinancialNewsMedia
Topics Death
Exposures Death
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
Via InvestorPlace
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
Why AeroClean Technologies Shares Are Trading Higher By Around 38%, Here Are 58 Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
Autolus Therapeutics Stock Jumps After Bristol Myers Pact For Safety Switch System
Via Benzinga
Autolus Therapeutics Announces Collaboration with Bristol Myers Squibb for Use of Autolus’ Proprietary Safety Switch System
From Autolus Therapeutics plc
Via Globe NewsWire
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
The Daily Biotech Pulse: AstraZeneca's 3 Product Updates, Jazz Pharma Licenses Sleeping Disorder Product, Argenx Aces Bleeding Disorder Study
Via Benzinga
Recap: Autolus Therapeutics Q4 Earnings
Via Benzinga
The Week Ahead In Biotech (March 6-12): Quiet Week On Tap With Earnings Season Reaching It Final Leg
Via Benzinga
40 Stocks Moving In Monday's Mid-Day Session
Via Benzinga
58 Biggest Movers From Yesterday
Via Benzinga
Why Autolus Therapeutics Stock Jumped 25% Today
Via The Motley Fool
64 Biggest Movers From Yesterday
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.